Lexeo Therapeutics, Inc. (LXEO) › RevenueLexeo Therapeutics, Inc. (LXEO) — RevenueAnnual figures by fiscal year, from SEC filings.Fiscal YearRevenueChange YoY2022$654.0K—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share